ResultsIQ › Latest results › Novartis India Limited
Novartis India Limited strategy deck summary
NSE: NOVARTIND · BSE: 500672
Strategy deck of 11 Sep 2026, summarised by AI from the filing.
NIL acquired Minipress trademark rights from Pfizer Inc. for ₹1,250 cr; brand revenue was ₹228 cr (MAT Jul'26).
Key takeaways
- Minipress XL NIL acquired Minipress trademark rights from Pfizer Inc. for ₹1,250 cr; brand revenue was ₹228 cr (MAT Jul'26).
- Field force A 900+ member field force is planned to cover ~150,000 HCPs pan-India, replacing partner-led distribution.
- Revenue trend Revenue declined from ₹379 cr in FY23 to ₹335 cr in FY26, a -2% CAGR.
Novartis India Limited earnings call, investor presentation and press release summaries
- Other events: Investor meet (11 Sep 2026), Strategy deck (11 Sep 2026)
Figures from the company's filings with NSE and BSE. Not investment advice.